[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588617":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":37,"collaborators":41,"id":113,"slug":114,"hasResults":115,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":7,"eligibilityCriteria":119,"healthyVolunteers":115,"sex":120,"minAge":121,"maxAge":122,"enrollmentInfo":123,"targetDuration":7,"studyType":126,"phases":7,"briefSummary":127,"conditions":128,"keywords":130,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"Huashan Hospital","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Gu Yuxiang, PhD","department of Neurosurgery, Huashan Hospital,Fudan University","STUDY_CHAIR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Gao Chao, PhD","CONTACT","18916960799","gc_huashanneuro@sina.com",[20],{"facility":21,"status":22,"city":23,"state":24,"zip":7,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Huashan hospital","RECRUITING","Shanghai","Shanghai Municipality","China","CN",{"type":28,"coordinates":29},"Point",[30,31],121.45806,31.22222,{"lat":31,"lon":30},[34],{"name":35,"role":16,"phone":36,"phoneExt":7,"email":18},"Gao Chao","+86 18916960799",{"type":38,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Yuxiang Gu","Vice-president of Huashan Hospital west campus",[42,44,46,48,50,52,54,56,58,61,63,65,67,69,71,73,75,77,79,81,83,85,87,89,91,93,95,97,99,101,103,105,107,109,111],{"name":43,"class":6},"Xinqiao Hospital of Chongqing",{"name":45,"class":6},"Ningbo No.2 Hospital",{"name":47,"class":6},"Eighth Affiliated Hospital, Sun Yat-sen University",{"name":49,"class":6},"Second Affiliated Hospital of Nanchang University",{"name":51,"class":6},"Jiangxi Provincial People's Hopital",{"name":53,"class":6},"Zhengzhou Central Hospital",{"name":55,"class":6},"Xuchang Central Hospital",{"name":57,"class":6},"Second People's Hospital of Hunan",{"name":59,"class":60},"People's Hospital Of Ningxiang City","UNKNOWN",{"name":62,"class":6},"The First People's Hospital of Changde City",{"name":64,"class":60},"HUANG GANG Central Hospital",{"name":66,"class":6},"Xianning Central Hospital",{"name":68,"class":6},"Jingzhou Central Hospital",{"name":70,"class":6},"Yichang Central People's Hospital",{"name":72,"class":6},"The First People's Hospital of Changzhou",{"name":74,"class":6},"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",{"name":76,"class":6},"Northern Jiangsu People's Hospital",{"name":78,"class":6},"Suzhou Municipal Hospital",{"name":80,"class":6},"Jiangsu Taizhou People's Hospital",{"name":82,"class":6},"Huadong Hospital",{"name":84,"class":6},"RenJi Hospital",{"name":86,"class":6},"Shanghai Zhongshan Hospital",{"name":88,"class":60},"Shanghai Fourth People's Hospital",{"name":90,"class":60},"Shanghai Donglei Brain Hospital",{"name":92,"class":6},"Shanghai Pudong New Area People's Hospital",{"name":94,"class":6},"Shanghai East Hospital of Tongji University",{"name":96,"class":6},"First Affiliated Hospital Xi'an Jiaotong University",{"name":98,"class":6},"Second Affiliated Hospital of Xi'an Jiaotong University",{"name":100,"class":6},"Tangshan Gongren Hospital",{"name":102,"class":6},"The Second Hospital of Hebei Medical University",{"name":104,"class":6},"Hebei General Hospital",{"name":106,"class":6},"Xingtai People's Hospital",{"name":108,"class":6},"Peking University First Hospital",{"name":110,"class":60},"THE AFFILIATED SUZHOU HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL",{"name":112,"class":6},"The Second Affiliated Hospital of Kunming Medical University","100588617","clinical-safety-and-efficacy-of-flow-diverter-in-the-treatment-of-intracranial-aneurysms-100588617",false,"NCT06943729","Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms","Clinical Safety and Efficacy of Flow Diverter in the Treatment of Intracranial Aneurysms","Inclusion Criteria:\n\n1)18 years ≤80 years; 2) intracranial aneurysm diagnosed by CTA, MRA or DSA (Including wide-necked aneurysms (neck width ≥4mm or Dome\u002Fneck ratio \\\u003C2), saccular, fusiform aneurysms, recurrent saccular aneurysms and dissecting aneurysms, and the diameter of the parent vessel ≥ 2.0 mm and ≤ 6.0 mm; the location includes: anterior circulation C3 segment and above of internal carotid artery, distal artery of Willis circle, posterior circulation V4 segment of vertebral artery and basilar artery and its main branches; 3) Voluntary participation in this study and signing of the Informed Consent Form (ICF).\n\nExclusion Criteria:\n\n1)AVM related aneurysm; 2) Acute ruptured aneurysm; 3) Severe stenosis or tortuosity of intracranial artery, or anatomical abnormality, which makes it difficult for the device to reach the lesion ; 4) Patients with hemorrhagic or ischemic stroke within 30 days; 5) Modified Rankin Score (mRS)\\>2 points before operation; 6) Patients with life expectancy less than 12 months; 7) Patients with definite history of allergy to cobalt-chromium alloy and platinum-tungsten alloy materials; Allergy to contrast media; 8) antiplatelet (PLT)\\\u003C100×10\\^ 9 \u002FL or\u002Fand anticoagulation contraindicated; 9) pregnant or lactating women; 10) other study participants who were assessed by the investigator as unsuitable for participation in the study.\n\nIntraoperative exclusion criteria: 1) acute rupture and hemorrhage of aneurysm during operation; 2) failure of FD implantation; 3) thrombosis in stent; 4) stent mal-apposition.","ALL","18 Years","80 Years",{"count":124,"type":125},523,"ESTIMATED","OBSERVATIONAL","To collect the safety and effectiveness data of flow-di in the treatment of intracranial aneurysms in real-world clinical practice, verify its classification of treatment strategies for aneurysms of different locations and shapes, and optimize postoperative medication regimen, provide long-term evidence-based basis for clinical treatment of intracranial aneurysms, and build a database.",[129],"Flow Diverter",[129,131],"Intracranial Aneurysm","2025-08-22",{"date":134,"type":135},"2025-08-29","ACTUAL",{"date":137,"type":135},"2025-04-27",{"date":139,"type":125},"2027-04-30",{"name":5,"class":6},1]